 Gabriella ten Have
Concepts (210)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keto Acids | 2 | 2022 | 12 | 1.500 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2022 | 39 | 1.440 |
Why?
| | Pseudomonas Infections | 3 | 2019 | 50 | 1.270 |
Why?
| | Amino Acids | 8 | 2023 | 373 | 1.120 |
Why?
| | Sepsis | 4 | 2019 | 227 | 1.070 |
Why?
| | Disease Models, Animal | 7 | 2019 | 1419 | 0.890 |
Why?
| | Dietary Supplements | 6 | 2024 | 445 | 0.870 |
Why?
| | Muscle, Skeletal | 11 | 2021 | 781 | 0.850 |
Why?
| | Liver | 11 | 2024 | 1123 | 0.750 |
Why?
| | Pseudomonas aeruginosa | 3 | 2019 | 74 | 0.720 |
Why?
| | Swine | 11 | 2024 | 408 | 0.700 |
Why?
| | Arginine | 6 | 2022 | 185 | 0.630 |
Why?
| | Phenylalanine | 3 | 2017 | 131 | 0.620 |
Why?
| | Valerates | 3 | 2024 | 38 | 0.590 |
Why?
| | Dietary Proteins | 2 | 2011 | 243 | 0.550 |
Why?
| | Oligopeptides | 2 | 2015 | 95 | 0.540 |
Why?
| | Postprandial Period | 3 | 2017 | 70 | 0.540 |
Why?
| | Animals | 25 | 2024 | 13173 | 0.480 |
Why?
| | Nitric Oxide | 5 | 2022 | 259 | 0.420 |
Why?
| | Kidney | 6 | 2021 | 686 | 0.410 |
Why?
| | Ammonia | 5 | 2020 | 77 | 0.400 |
Why?
| | Diet, Protein-Restricted | 1 | 2011 | 9 | 0.390 |
Why?
| | Tryptophan | 1 | 2011 | 100 | 0.370 |
Why?
| | Tissue Distribution | 4 | 2021 | 167 | 0.360 |
Why?
| | Gastrointestinal Tract | 1 | 2011 | 102 | 0.360 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 132 | 0.340 |
Why?
| | Kinetics | 3 | 2022 | 635 | 0.330 |
Why?
| | Female | 23 | 2024 | 26981 | 0.330 |
Why?
| | Proteins | 3 | 2020 | 350 | 0.320 |
Why?
| | Leucine | 2 | 2021 | 118 | 0.290 |
Why?
| | Critical Illness | 4 | 2023 | 300 | 0.280 |
Why?
| | Viscera | 2 | 2021 | 23 | 0.280 |
Why?
| | Sarcopenia | 3 | 2017 | 94 | 0.280 |
Why?
| | Nitrogen | 2 | 2020 | 70 | 0.270 |
Why?
| | Peptides | 1 | 2007 | 221 | 0.260 |
Why?
| | Muscles | 2 | 2020 | 104 | 0.260 |
Why?
| | Glutamine | 4 | 2010 | 173 | 0.250 |
Why?
| | Hyperammonemia | 3 | 2017 | 23 | 0.240 |
Why?
| | Cyclopropanes | 1 | 2024 | 24 | 0.230 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2024 | 28 | 0.230 |
Why?
| | Body Composition | 3 | 2021 | 326 | 0.230 |
Why?
| | Liver Failure, Acute | 3 | 2012 | 56 | 0.230 |
Why?
| | Fatty Acids | 1 | 2024 | 145 | 0.220 |
Why?
| | Metabolic Networks and Pathways | 2 | 2021 | 92 | 0.220 |
Why?
| | Jejunum | 2 | 2020 | 56 | 0.210 |
Why?
| | Hydroxy Acids | 1 | 2022 | 9 | 0.200 |
Why?
| | Sus scrofa | 3 | 2017 | 37 | 0.200 |
Why?
| | Obesity, Morbid | 1 | 2022 | 80 | 0.190 |
Why?
| | Citrulline | 4 | 2022 | 100 | 0.190 |
Why?
| | Lactation | 1 | 2022 | 59 | 0.190 |
Why?
| | Intestines | 2 | 2020 | 171 | 0.190 |
Why?
| | Male | 17 | 2024 | 25718 | 0.190 |
Why?
| | Hemiterpenes | 1 | 2021 | 11 | 0.180 |
Why?
| | Sciuridae | 1 | 2020 | 3 | 0.180 |
Why?
| | Hibernation | 1 | 2020 | 4 | 0.180 |
Why?
| | Muscular Atrophy | 1 | 2021 | 71 | 0.180 |
Why?
| | Body Fluid Compartments | 1 | 2020 | 3 | 0.180 |
Why?
| | Vitamin B Deficiency | 1 | 2020 | 5 | 0.180 |
Why?
| | Chromatography, Liquid | 4 | 2023 | 229 | 0.180 |
Why?
| | Hyperhomocysteinemia | 1 | 2020 | 30 | 0.180 |
Why?
| | p-Aminohippuric Acid | 1 | 2020 | 11 | 0.180 |
Why?
| | Lung | 2 | 2019 | 512 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 4 | 2023 | 237 | 0.170 |
Why?
| | Crosses, Genetic | 2 | 2017 | 32 | 0.170 |
Why?
| | Homocysteine | 1 | 2020 | 127 | 0.170 |
Why?
| | Digestion | 2 | 2011 | 29 | 0.170 |
Why?
| | Muscle Proteins | 3 | 2017 | 320 | 0.170 |
Why?
| | Muscle Weakness | 1 | 2020 | 45 | 0.170 |
Why?
| | Methionine | 1 | 2020 | 134 | 0.170 |
Why?
| | Proteolysis | 2 | 2017 | 96 | 0.160 |
Why?
| | Isotope Labeling | 1 | 2019 | 53 | 0.160 |
Why?
| | Ileum | 1 | 2019 | 87 | 0.160 |
Why?
| | Urea | 3 | 2020 | 80 | 0.160 |
Why?
| | Metabolome | 1 | 2020 | 92 | 0.160 |
Why?
| | Motor Activity | 1 | 2020 | 222 | 0.160 |
Why?
| | Nitrogen Isotopes | 2 | 2017 | 38 | 0.160 |
Why?
| | Muscle Strength | 1 | 2020 | 128 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 253 | 0.160 |
Why?
| | Models, Biological | 2 | 2015 | 723 | 0.150 |
Why?
| | Humans | 16 | 2024 | 50389 | 0.150 |
Why?
| | Animal Structures | 1 | 2017 | 3 | 0.140 |
Why?
| | Clinical Chemistry Tests | 1 | 2017 | 3 | 0.140 |
Why?
| | Blood Gas Analysis | 1 | 2017 | 31 | 0.140 |
Why?
| | Inflammation | 2 | 2022 | 608 | 0.140 |
Why?
| | Liver Circulation | 1 | 2017 | 22 | 0.140 |
Why?
| | Rifamycins | 1 | 2017 | 5 | 0.140 |
Why?
| | Indicator Dilution Techniques | 1 | 2017 | 12 | 0.140 |
Why?
| | Venae Cavae | 1 | 2017 | 10 | 0.140 |
Why?
| | Carbon Isotopes | 1 | 2017 | 71 | 0.140 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2016 | 3 | 0.140 |
Why?
| | Protein Stability | 1 | 2017 | 43 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2017 | 77 | 0.140 |
Why?
| | Infusions, Intravenous | 1 | 2017 | 213 | 0.130 |
Why?
| | Bile Ducts | 1 | 2016 | 49 | 0.130 |
Why?
| | Catheterization, Central Venous | 1 | 2017 | 85 | 0.130 |
Why?
| | Hemodynamics | 1 | 2017 | 266 | 0.130 |
Why?
| | Arginase | 2 | 2012 | 37 | 0.130 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 7 | 0.120 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 455 | 0.120 |
Why?
| | Carnitine | 1 | 2015 | 63 | 0.120 |
Why?
| | Middle Aged | 8 | 2024 | 12460 | 0.120 |
Why?
| | Liver Cirrhosis | 1 | 2017 | 229 | 0.120 |
Why?
| | Lipid Metabolism | 1 | 2015 | 176 | 0.110 |
Why?
| | Aging | 1 | 2017 | 675 | 0.100 |
Why?
| | Metabolic Diseases | 1 | 2012 | 40 | 0.100 |
Why?
| | Hybridization, Genetic | 1 | 2011 | 8 | 0.100 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2011 | 18 | 0.100 |
Why?
| | Gelatin | 1 | 2011 | 23 | 0.100 |
Why?
| | Injections, Intraperitoneal | 3 | 2020 | 57 | 0.100 |
Why?
| | Animal Feed | 1 | 2011 | 56 | 0.090 |
Why?
| | Electric Impedance | 2 | 2021 | 42 | 0.090 |
Why?
| | Double-Blind Method | 2 | 2024 | 682 | 0.090 |
Why?
| | Organ Specificity | 3 | 2020 | 109 | 0.090 |
Why?
| | Postoperative Care | 1 | 2011 | 105 | 0.090 |
Why?
| | Models, Animal | 1 | 2011 | 228 | 0.090 |
Why?
| | Energy Intake | 1 | 2011 | 171 | 0.090 |
Why?
| | Mice, Inbred C3H | 2 | 2020 | 84 | 0.090 |
Why?
| | Physical Conditioning, Animal | 2 | 2020 | 54 | 0.090 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2010 | 10 | 0.090 |
Why?
| | Metabolomics | 2 | 2020 | 133 | 0.080 |
Why?
| | Aged | 4 | 2024 | 9590 | 0.070 |
Why?
| | Dietary Fiber | 1 | 2007 | 19 | 0.070 |
Why?
| | Portal Vein | 1 | 2007 | 26 | 0.070 |
Why?
| | Intestinal Absorption | 1 | 2007 | 47 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2008 | 127 | 0.070 |
Why?
| | Dietary Carbohydrates | 1 | 2007 | 90 | 0.070 |
Why?
| | Albumins | 1 | 2006 | 31 | 0.070 |
Why?
| | Mice | 5 | 2020 | 5688 | 0.070 |
Why?
| | Dietary Fats | 1 | 2007 | 126 | 0.070 |
Why?
| | Intestine, Small | 1 | 2007 | 111 | 0.070 |
Why?
| | Creatinine | 1 | 2006 | 144 | 0.070 |
Why?
| | United States | 1 | 2017 | 4913 | 0.070 |
Why?
| | Glutamic Acid | 1 | 2006 | 110 | 0.060 |
Why?
| | Renal Dialysis | 1 | 2006 | 171 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2017 | 562 | 0.060 |
Why?
| | Enteral Nutrition | 2 | 2021 | 149 | 0.060 |
Why?
| | Autophagy | 2 | 2017 | 167 | 0.060 |
Why?
| | Eicosapentaenoic Acid | 1 | 2024 | 21 | 0.060 |
Why?
| | Docosahexaenoic Acids | 1 | 2024 | 28 | 0.060 |
Why?
| | Endotoxemia | 1 | 2004 | 33 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2020 | 1148 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2017 | 1582 | 0.050 |
Why?
| | Prospective Studies | 2 | 2021 | 2414 | 0.050 |
Why?
| | Organ Dysfunction Scores | 1 | 2021 | 18 | 0.050 |
Why?
| | gamma-Glutamyl Hydrolase | 1 | 2020 | 2 | 0.050 |
Why?
| | Arctic Regions | 1 | 2020 | 3 | 0.050 |
Why?
| | Basal Metabolism | 1 | 2021 | 32 | 0.050 |
Why?
| | Quadriceps Muscle | 1 | 2021 | 47 | 0.050 |
Why?
| | Myofibrils | 1 | 2020 | 20 | 0.050 |
Why?
| | Vitamin B Complex | 1 | 2020 | 22 | 0.040 |
Why?
| | Arousal | 1 | 2020 | 99 | 0.040 |
Why?
| | Rats | 2 | 2017 | 3287 | 0.040 |
Why?
| | Portal System | 1 | 2020 | 17 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 171 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 224 | 0.040 |
Why?
| | Phenols | 1 | 2020 | 81 | 0.040 |
Why?
| | Ultrasonography | 1 | 2021 | 438 | 0.040 |
Why?
| | Quality of Life | 1 | 2024 | 844 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2019 | 284 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 1590 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 465 | 0.040 |
Why?
| | Gastric Bypass | 1 | 2017 | 20 | 0.040 |
Why?
| | Affect | 1 | 2017 | 98 | 0.040 |
Why?
| | Fasting | 1 | 2017 | 75 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2017 | 54 | 0.030 |
Why?
| | Base Composition | 1 | 2016 | 29 | 0.030 |
Why?
| | Ligation | 1 | 2016 | 62 | 0.030 |
Why?
| | Hepatic Encephalopathy | 1 | 2016 | 29 | 0.030 |
Why?
| | Catheterization | 1 | 2017 | 101 | 0.030 |
Why?
| | Adult | 3 | 2017 | 13568 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 190 | 0.030 |
Why?
| | Eating | 1 | 2016 | 158 | 0.030 |
Why?
| | Homeostasis | 1 | 2017 | 204 | 0.030 |
Why?
| | Acetylcarnitine | 1 | 2015 | 7 | 0.030 |
Why?
| | Palmitoylcarnitine | 1 | 2015 | 7 | 0.030 |
Why?
| | Plant Oils | 1 | 2015 | 16 | 0.030 |
Why?
| | Weight Gain | 1 | 2016 | 236 | 0.030 |
Why?
| | Catheters, Indwelling | 1 | 2015 | 57 | 0.030 |
Why?
| | Cognition | 1 | 2017 | 314 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 1785 | 0.030 |
Why?
| | Insulin | 1 | 2017 | 466 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2015 | 77 | 0.030 |
Why?
| | Blood Glucose | 1 | 2017 | 443 | 0.030 |
Why?
| | Body Mass Index | 1 | 2017 | 669 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 216 | 0.030 |
Why?
| | Exercise | 1 | 2017 | 505 | 0.030 |
Why?
| | Nitric Oxide Synthase | 1 | 2012 | 74 | 0.030 |
Why?
| | Portacaval Shunt, Surgical | 1 | 2012 | 10 | 0.030 |
Why?
| | Ornithine | 1 | 2012 | 19 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2012 | 257 | 0.020 |
Why?
| | Food Deprivation | 1 | 2010 | 30 | 0.020 |
Why?
| | Alleles | 1 | 2010 | 253 | 0.020 |
Why?
| | Obesity | 1 | 2017 | 1125 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 539 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2010 | 543 | 0.020 |
Why?
| | Young Adult | 1 | 2017 | 4064 | 0.020 |
Why?
| | Sex Factors | 1 | 2010 | 702 | 0.020 |
Why?
| | Hepatorenal Syndrome | 1 | 2006 | 11 | 0.020 |
Why?
| | Nitrites | 1 | 2006 | 32 | 0.020 |
Why?
| | Catecholamines | 1 | 2006 | 46 | 0.020 |
Why?
| | Nitrates | 1 | 2006 | 30 | 0.020 |
Why?
| | Vascular Resistance | 1 | 2006 | 56 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2006 | 33 | 0.020 |
Why?
| | Parenteral Nutrition | 1 | 2006 | 27 | 0.020 |
Why?
| | Random Allocation | 1 | 2006 | 287 | 0.020 |
Why?
| | Radioactive Tracers | 1 | 2004 | 9 | 0.010 |
Why?
| | Blood Pressure | 1 | 2006 | 529 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 196 | 0.010 |
Why?
| | Algorithms | 1 | 2006 | 618 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 2934 | 0.010 |
Why?
|
|
ten Have's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|